View the LUCILETER registration information details.
Back to drug list
ItemsDrug Registration information
ID1745
No1745
Brand NameLUCILETER
IngredientsLETERMOVIR 240 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AND DISESEASE IN ADULT AND PAEDIATRIC PATIENTS 6 MONTHS OF GAE AND OLDER AND WEIGHING AT LEAST 6 KG WHO ARE CMV-SEROPOSITIVE RECIEPIENTS OF AN ALLOGENEIC HEMATOPOITIC STEM CELL TRANSPLANT, PROPHYLAXIS OF CMV DISEASE IN ADULT AND PAEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER AND WEIGHNING AT LEAST 40 KG WHO ARE KIDNEY TRANSPLANT RECEIPIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPEINT CMV SERONEGATIVE)
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionORANGE COLORED FILM COATED TABLET, WITH LETTER LUCIUS AND PLAIN ON THE OTHER SIDE
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 L 1340/25
FDD Registration Date45768
Expiry Date47593
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA